×

Use of NF-kB Inhibition in Combination Therapy for Cancer

  • US 20070105751A1
  • Filed: 09/27/2006
  • Published: 05/10/2007
  • Est. Priority Date: 10/28/1997
  • Status: Active Grant
First Claim
Patent Images

1. A method of enhancing the cytotoxic effects of radiation therapy, comprising administering to a mammalian subject in need of said radiation therapy a therapeutically effective amount of NF-κ

  • B inhibitor in conjunction with the administration of the radiation therapy whereby the cytotoxic effect of said radiation therapy is increased compared to that which would occur in the absence of NF-κ

    B inhibitor.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×